FDA Investigator: Kent C. Faul
- Kent C. Faul first started conducting FDA inspections in 2000, with the last inspection in 2007. Over that time, Kent C. Faul has conducted 52 inspections at 46 companies across 48 sites.
Get Kent Faul's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Cody Laboratories, Inc., Cody | 2007
Out-of-stock
Kent C. Faul
Human Drug Form 483
FDA 483 Dr. Reddy's Laboratories Ltd., Quthbullapur, Hyderabad | 2007
Out-of-stock
Kent C. Faul
Human Drug Form 483
FDA 483 Dr. Reddy's Laboratories, Unit III, Jinnaram Mandal, Medak District | 2007
Out-of-stock
Kent C. Faul
Human Drug Form 483
FDA 483 Southwest Bio-Labs, Inc., Las Cruces | 2006
Out-of-stock
Kent C. Faul
Animal Drugs & Feed Form 483
FDA 483 Synthon Bv, Nijmegen | 2006
Out-of-stock
Kent C. Faul
Human Drug Form 483
FDA 483 Glaxosmithkline, Montrose | 2006
Out-of-stock
Kent C. Faul
Human Drug Form 483
FDA 483 Cosma SPA, Ciserano | 2006
Out-of-stock
Kent C. Faul
Animal Drugs & Feed Form 483
FDA 483 Polfa Tarchomin S.A., Warszawa | 2006
Out-of-stock
Kent C. Faul
Human Drug Form 483
FDA 483 Beijing Keyifeng Biotech Development Co., Ltd., Beijing | 2005
Out-of-stock
Kent C. Faul
Animal Drugs & Feed Form 483
FDA 483 Southwest Synthetic Pharmaceutical Corporation Limited, Chongqing | 2005
Out-of-stock
Kent C. Faul
Human Drug Form 483
FDA 483 Chunghwa Chemical Synthesis & Biotech. Ltd, New Taipei City | 2005
Out-of-stock
Kent C. Faul
Human Drug Form 483
FDA 483 Macleod Pharmaceuticals, Inc, Fort Collins | 2005
Out-of-stock
Kent C. Faul
Animal Drugs & Feed Form 483
FDA 483 Gilead Sciences Ltd., Dublin | 2005
Out-of-stock
Kent C. Faul
Human Drug Form 483
FDA 483 Novartis Pharma Stein AG, Stein | 2005
Out-of-stock
Kent C. Faul
Human Drug Form 483
FDA 483 Novartis Pharma AG, Basel | 2005
Out-of-stock
Kent C. Faul
Animal Drugs & Feed Form 483
FDA 483 Novartis Pharma Stein AG, Stein | 2005
Out-of-stock
Kent C. Faul
Human Drug Form 483
FDA 483 Novartis Pharma AG, Basel | 2005
Out-of-stock
Kent C. Faul
Animal Drugs & Feed Form 483
FDA 483 Novartis Pharma Schweizerhalle Ag, Schweizerhalle | 2005
Out-of-stock
Kent C. Faul
Animal Drugs & Feed Form 483
FDA 483 Fersinsa Gb, Ramos Arizpe | 2004
Out-of-stock
Kent C. Faul
Animal Drugs & Feed Form 483
FDA 483 Signa S.A. de C.V., Toluca, Mexico | 2004
Out-of-stock
Kent C. Faul
Human Drug Form 483
FDA 483 Tianjin Zhong Xin Pharmaceutical, Tianjin | 2003
Out-of-stock
Kent C. Faul
Human Drug Form 483
FDA 483 Shanghai Zhongxi Sunve Pharmaceutical Co., Ltd., Shanghai | 2003
Out-of-stock
Kent C. Faul
Animal Drugs & Feed Form 483
FDA 483 Wuxi Kaili Pharmaceutical Company LTD., Yixing City | 2003
Out-of-stock
Kent C. Faul
Human Drug Form 483
FDA 483 Shanghai Fourth Pharmaceuticals, Ltd., Shanghai, China | 2002
Out-of-stock
Kent C. Faul
Animal Drugs & Feed Form 483
FDA 483 Sichuan Long March Pharmaceutical Co., Ltd., Leshan | 2002
Out-of-stock
Kent C. Faul
Animal Drugs & Feed Form 483
FDA 483 Nanjing Pharmaceutical Factory Co., Ltd., Nanjing | 2002
Out-of-stock
Kent C. Faul
Animal Drugs & Feed Form 483
FDA 483 USL Pharma Inc. dba Upsher Smith Laboratories, Inc., Denver | 2002
Out-of-stock
Kent C. Faul
Human Drug Form 483
Co-Investigators (20)
- Nancy G. Schmidt, FDA Investigator
- Gwyn G. Dickinson, FDA Investigator
- Teena H. Aiken, FDA Investigator
- Patricia H. Dlugosz, FDA Investigator
- Jeffery A. Hangartner, FDA Investigator
- Shirley J. Berryman, FDA Investigator
- James P. McReavey, FDA Investigator
- Gerardo Z. Vazquez, FDA Investigator
- Patricia A. Brown, FDA Investigator
- Keith S. Ehrlich, FDA Investigator
- Robert C. Horan, FDA Investigator
- Katherine Szestypalow, FDA Investigator
- Grace E. McNally, FDA Investigator
- Justin R. Carr, FDA Investigator
- Susan L. Young, FDA Investigator
- Yvonne E. Lozano, FDA Investigator
- Richard H. Penta, FDA Investigator
- Karen G. Hirshfield, FDA Investigator
- Paraluman S. Leonin, FDA Investigator
- Michael J. Kuchta, FDA Investigator